| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 12/16/2004 | WO2004089329A3 Topical compositions comprising n-acetylamino acids or related n-acetyl compounds |
| 12/16/2004 | WO2004087043A3 Stable ophthalmic formulation containing an antibiotic and a corticosteroid |
| 12/16/2004 | WO2004082594A3 Alginate sponge and preparation method thereof |
| 12/16/2004 | WO2004082590A3 A low dose corticosteroid composition |
| 12/16/2004 | WO2004075901A3 Compositon for increasing levels of hormones and a method for preparation of said composition |
| 12/16/2004 | WO2004073033A3 Material incapsulation system |
| 12/16/2004 | WO2004071545A3 Compositions for neuronal tissue regeneration |
| 12/16/2004 | WO2004071494A3 Lipophilic compositions |
| 12/16/2004 | WO2004071374A3 Once a day orally administered pharmaceutical compositions |
| 12/16/2004 | WO2004064735A3 Treatment of benign prostatic hyperplasia |
| 12/16/2004 | WO2004058140B1 Non-pegylated long-circulating liposomes |
| 12/16/2004 | WO2004046202A3 Bio-degradable colloid particles, in particular for pulmonary applications |
| 12/16/2004 | WO2004032963A3 Photokinetic delivery of biologically active substances using pulsed incoherent light |
| 12/16/2004 | WO2004022132A3 Nebulizer having a solvent and an inert substrate impregnated with a pharmaceutical ingredient |
| 12/16/2004 | WO2003090684A8 Polymer compositions containing a macrocyclic triene compound |
| 12/16/2004 | WO2003088949A3 Matrix comprising a bioactive component containing phospholipid |
| 12/16/2004 | WO2003015667A8 Method and intra sclera implant for treatment of glaucoma and presbyopia |
| 12/16/2004 | US20040254565 Implantable device for delivering drugs using orifice mechanism capable of low fluid flow rates |
| 12/16/2004 | US20040254564 Medical device for fluid delivery having low fluid flow rate |
| 12/16/2004 | US20040254563 Method for manufacturing an orifice mechanism capable of low fluid flow rates |
| 12/16/2004 | US20040254544 Orifice device for delivering drugs at low fluid flow rates |
| 12/16/2004 | US20040254495 Standardized swallow challenge medium and method of use for esophageal function testing |
| 12/16/2004 | US20040254352 Comprising active agent and lipid-polymer conjugate, obtainable from an amphiphilic lipid, consisting of at least one hydrophobic apolar moiety and a hydrophylic polar head group, and a polymer or monomeric precursor therefor, the polymer being a poly(amino acid) or a poly(amino acid) derivative |
| 12/16/2004 | US20040254252 Tpoical applying a mixture containing alkoxybenzaldehyde compound |
| 12/16/2004 | US20040254245 Using extract of olive leaves; moisturizers; antiinflammatory agents; prevention of acne |
| 12/16/2004 | US20040254243 Drink preparation comprising ketoprofen and its use in the simultaneous treatment of conditions causing fever, inflammation and pain in a herd of animals |
| 12/16/2004 | US20040254223 Process for the preparation of amorphous form of torsemide |
| 12/16/2004 | US20040254210 Pharmaceutical compositions comprising colloidal silicon dioxide |
| 12/16/2004 | US20040254202 Method of promoting sleep using topical administration of vasoactive agents |
| 12/16/2004 | US20040254197 Injections for eye tissues containing drug bonded to polyethlene glycol |
| 12/16/2004 | US20040254194 Treatment of bacterial diseases of the respiratory organs |
| 12/16/2004 | US20040254165 Vitiligo; skin cancer; control skin coloring |
| 12/16/2004 | US20040254146 Carboxylate salts of galantamine and their pharmaceutical use |
| 12/16/2004 | US20040254143 Compositions and methods for the treatment or prevention of inflammation |
| 12/16/2004 | US20040254137 Nucleotide sequences; for therapy of bone disorders, chondrondysplasis; biodrug; activation caspase signaling cascade |
| 12/16/2004 | US20040254129 In aqueous solution;prevent cell damage; mixture with drug or nitritional supplment |
| 12/16/2004 | US20040254128 Treatment and prevention of heat shock protein-associated diseases and conditions |
| 12/16/2004 | US20040254107 Biphasic mixtures of glp-1 and insulin |
| 12/16/2004 | US20040254096 Mucin synthesis inhibitors |
| 12/16/2004 | US20040254087 Core of active material with wax coating |
| 12/16/2004 | US20040253731 Solution comprising surfactant, hydrophobic phase and hydrophilic phase comprising plurality of microcapsules containing functional in vitro eukaryotic expression system for transfer of heterologous into cells |
| 12/16/2004 | US20040253690 Process for producing isomaltose and use thereof |
| 12/16/2004 | US20040253360 Hard frozen food containing alcohol |
| 12/16/2004 | US20040253357 Includes cycle comprising step of applying polyol syrup with richness of greater than 80%, step of drying cores, wherein this cycle does not comprise a standing time between step of applying polyol syrup and step of drying cores; produces of dragee-coated products of very good quality in short time |
| 12/16/2004 | US20040253326 Composition for increasing levels of hormones and a method for preparation of said composition |
| 12/16/2004 | US20040253318 Preventing, alleviating symptoms of a skin condition with a complexes, such as lauryliminodipropionic acid tocopheryl phosphate; penetrating and absorption into skin; inflammation, erythema, wound, burn, dermatitis, gingivitis, sunburn, heat burn, psoriasis; cosmetics |
| 12/16/2004 | US20040253316 Production scale method of forming microparticles |
| 12/16/2004 | US20040253315 A stable aqueous solution comprising a shell-core polyamideether copolymer, drug is carried in core part; saccharides, polyoxyethylene glycol as a stabilizing agent |
| 12/16/2004 | US20040253314 Melt extrusion of salts of active ingredients |
| 12/16/2004 | US20040253312 A solid high density core and a porous shell readily soluble in gastrointestinal fluids; shell is applied to the core by dipping, molding; less than about 50% crystallizable sugar, gelatin; free of charge control agents |
| 12/16/2004 | US20040253311 Multi-layer tablet comprising non-steroidal anti-inflammatory drugs, decongestants and non-sedating antihist amines |
| 12/16/2004 | US20040253310 A opioid matrix is coated with a cellulose mixture layer; controlling the release of opioid, preventing the side effect of immediate release opioid in blood stream; water soluble and water insoluble celluloses; pain treatment |
| 12/16/2004 | US20040253309 Tablets are disintegrated in the mouth cavity; comprising enterosoluble substance polymer or fatty acid, water insoluble substance polymer or wax; controlling the drug release, preventing the side effect of sudden rise in the plasma concentration |
| 12/16/2004 | US20040253308 Surface-treated modafinil particles |
| 12/16/2004 | US20040253307 Sugar-free oral transmucosal solid dosage forms and uses thereof |
| 12/16/2004 | US20040253306 Sustained release formulations for nifedipine dextromethorphan, and danazol |
| 12/16/2004 | US20040253305 Pharmaceutical compositions of atorvastatin |
| 12/16/2004 | US20040253304 An ingestible capsule contains a drug inside, a electrical driving mechanism to drive the drug directly through an endothelial layer of the gastrointestinal tract; electrical apparatus, multicompartment electrodes, sensors; enhance the absorption of a drug, control release at target location |
| 12/16/2004 | US20040253302 Compositions and methods for treating lymphoma |
| 12/16/2004 | US20040253301 Transdermal therapeutic system comprising a reservoir type pressure sensitive adhesive layer and a back layer with uni-directional resilience |
| 12/16/2004 | US20040253300 Medication and method for remediating existing scars through transdermal, topical delivery of calcium channel blockers |
| 12/16/2004 | US20040253299 Controlled release drug delivery device; side effect reduction; Parkinson's disease |
| 12/16/2004 | US20040253294 A crosslinked, acidic, high molecular weight gelatin hydrogel obtained from alkali hydrolyzed collagen, impregnated with hepatocyte growth factor, and having an isoelectric point of 5 and a zeta potential between -15 and -20 mV; angiogenesis promoters; arterial diseases |
| 12/16/2004 | US20040253293 Rate controlled release of a pharmaceutical agent in a biodegradable device |
| 12/16/2004 | US20040253289 Natural plant compound with anti-HIV activity |
| 12/16/2004 | US20040253281 Inks include surface activated immobilized drug, controlled release agent, and have the ability to differentiate active ingredients by location and dosage; tatoos; vapor deposition; gene therapy |
| 12/16/2004 | US20040253280 Ophthalmic compositions containing a synergistic combination of two polymers |
| 12/16/2004 | US20040253277 Anaesthetic formulations of propofol |
| 12/16/2004 | US20040253276 Oil-in-water emulsion of a 1-carboxylate-6-arylsulfamoyl cyclohexene and synthetic and naturally occurring phospholipids; nitric oxide or cytokine prodution inhibitors; cardiovascular disorders, autoimmune dieseases, septic shock; improved stability during autoclave sterilization |
| 12/16/2004 | US20040253275 Pharmaceutical and cosmetic carrier or composition for topical application |
| 12/16/2004 | US20040253269 Use of dictyotal extracts in the production of a topical composition |
| 12/16/2004 | US20040253206 etoposide; hydrophobic drug attached to amphiphilic ethylene glycol oligomer or polymer via hydrolyzable bond; improves ability to penetrate blood-brain barrier; bond hydrolyzes in vivo, freeing the fully bioactive drug; improves solubility of the drug in the bloodstream; drug delivery to CNS |
| 12/16/2004 | US20040253202 Ophthalmic compositions containing a synergistic combination of three polymers |
| 12/16/2004 | US20040253195 biocompatible amphiphilic copolymer of hydrophilic and hydrophobic blocks, and a polylactic acid derivative having a terminal carboxy metal salt; hydrophilic outer shell and hydrophobic inner core physically trap hydrophobic drug; prolonged retention time in the bloodstream on delivery |
| 12/16/2004 | US20040253193 metronidazole and nystatin with a carrier; mouthwash |
| 12/16/2004 | US20040253192 Pullulan free edible film composition comprising a film forming agent and an antimicrobial agent which is cardamom oil; chewing gums, confections, mouthwashes, mouth sprays and edible thin films |
| 12/16/2004 | US20040253190 Breath Freshening and Oral Cleansing Product Using Citral |
| 12/16/2004 | US20040253189 Pullulan free edible films formed from maltodextrin, filler, and hydrocolloid mixture; chewing gums, confections, mouthwashes, and mouth sprays containing |
| 12/16/2004 | US20040253185 Medicated ink |
| 12/16/2004 | US20040251580 Natural rubber, chalk, a molecular sieve/medicament adduct, or silicone rubber, chalk and a molecular sieve/medicament adduct, extruded into a tubing immediately precured with 15 to 25% of the total radiation dose, cutting the tubing, sealing, sterilization |
| 12/16/2004 | DE202004015623U1 Lubricant, for use during sexual intercourse, incorporates a sexual stimulant which can also be used in a soap to give an arousal effect when washing |
| 12/16/2004 | DE10323966A1 Neue langwirksame Arzneimittelkombinationen zur Behandlung von Atemwegserkrankungen New long-acting drug combinations for the treatment of respiratory disorders |
| 12/16/2004 | DE10322123A1 Stable anionic liposome depot system for prolonged release of protein or peptide drugs, e.g. insulin, comprising phosphatidyl choline, cholesterol, anionic lipid(s) and cationic polymer |
| 12/16/2004 | DE10058384B4 Kosmetisches oder dermatologisches Mittel in Form eines cremigen Permanentschaums oder einer stabil aufgeschäumten Creme, deren Verwendung und Verfahren zur Herstellung des Mittels Cosmetic or dermatological composition in the form of a foam or creamy permanent stable foamed cream, their use and process for the preparation of the agent |
| 12/16/2004 | CA2528164A1 Solid preparation |
| 12/16/2004 | CA2528136A1 Transfection agents |
| 12/16/2004 | CA2527994A1 Process for producing microparticles |
| 12/16/2004 | CA2527988A1 Cosmetic patch and using method thereof, and cosmetic patch package |
| 12/16/2004 | CA2527926A1 Controlled release formulations |
| 12/16/2004 | CA2527914A1 Improved secretion of neublastin |
| 12/16/2004 | CA2527664A1 Implantable elastomeric depot compositions, uses thereof and method of manufacturing |
| 12/16/2004 | CA2527658A1 Methods and compositions for interferon therapy |
| 12/16/2004 | CA2526435A1 Polyamino acids functionalised with at least one hydrophobic group and applications thereof particularly therapeutic applications |
| 12/16/2004 | CA2521682A1 Delivery of immune response modifier compounds using metal-containing particulate support materials |
| 12/15/2004 | EP1486224A1 Method for manufacturing an orifice mechanism capable of low fluid flow rates |
| 12/15/2004 | EP1486223A1 Implantable device for delivering drugs using a capillary orifice for low fluid flow rates |
| 12/15/2004 | EP1486222A1 Orifice device for delivering drugs at low fluid flow rates |
| 12/15/2004 | EP1486221A1 Medical device for fluid delivery having low fluid flow rate |
| 12/15/2004 | EP1486209A2 Pharmaceutical formulations for the treatment of inflammatory bowel disease |
| 12/15/2004 | EP1486204A1 Powdery medicinal compositions for inhalation and process for producing the same |